Decoding Pleural Mesothelioma: Insights from a Ten-Year Study
Recently, a group of researchers studied 169 patients with pleural mesothelioma over ten years. They wanted to gain a deeper…
-
-
The Future of Mesothelioma Diagnosis: A Faster, More Affordable Solution
A new study’s groundbreaking findings show that using both MTAP and p16 IHC can be a powerful tool in diagnosing… -
Paradigm Shift in Mesothelioma Treatment: Targeting PD-1 Biomarker for Improved Outcomes
A recent study in mesothelioma patients opens a new chapter in the fight against this challenging disease. It enhances our… -
Meet FLT PET: A New Hope for Mesothelioma Patients
There’s a new tool called F18-Fluorothymidine (FLT) PET. It takes pictures inside the body and focuses on how the cancer… -
Cracking the Code: SPARC, the New Mesothelioma Diagnostic Marker
Scientists from Japan have found a new mesothelioma marker called SPARC that could help doctors diagnose this rare cancer. This… -
Immunotherapy’s Impact on the Mesothelioma Immune System
The battle against mesothelioma has seen significant developments in recent years. Many developments are with the introduction of immunotherapy as… -
Battling Mesothelioma: How PICC Devices Make a Difference in Patients’ Lives
Mesothelioma, a rare and aggressive cancer, often takes a silent toll on the lives of those affected. This disease, linked… -
The Persistence of Mesothelioma in a Post-Asbestos Era
Mesothelioma is a type of cancer caused by exposure to a harmful mineral called asbestos. It takes decades for mesothelioma… -
MTH1 Protein: A New Ally in the Fight Against Mesothelioma
Scientists are now investigating a protein known as MTH1. They are delving into its role in boosting the body’s immune… -
Evening Primrose Extract: Targeting TYMS for Mesothelioma Treatment
Recent studies have provided exciting insights into how evening primrose extract interacts with TYMS. TYMS is a protein crucial in…
